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Summary, general discussion and future perspectives
Summary
For erythropoiesis it is of utmost importance that cellular processes like proliferation.
differentiation and apoptosis are balanced in ordeÍ to generate sufficient erythrocytes, br.rt also
to prevent an excessive production of erythrocytes. Especially the presence or absence of
cytokines l ike erythropoietin (Epo) and stem cell factor (SCF) detennines the faith of
erythroid progenitor cells. These growth factors activate intracellular signal transduction
cascades that ult imately result in the expression or silencing of the appropriate genes and tum
the balance between proliferation, differentiation and apoptosis in the favorable direction.
In chapter two, we exarnined the role of the SH2-containing inositol phosphatase
(SHIP) on proliferation and apoptosis in the Epo-dependent cell l ine AS-82. Stable
overexpression of wild-type SHIP drd not affect Epo-induced proliferation, but apoptosis was
strongly enhanced in the absence of Epo. Epo-deprived cells showed an increase in caspase-3
and -9 activity, without a distinct effect on caspase-8 activity or mitochondrial depolarization.
Thc increase in apoptosis was not due to the inositol phosphatase activity of SHIP, since AS-
E2 cells stably expressing catalytically inactive SHIP showed a similar increase in apoptosis.
However, unlike overexpression of wild-type SHIP, overexpression of catalytically inactive
Sf{lP did reduce proliferation, indicating that the 5'-phosphatase activity of SHIP is l inked to
erythroid proliferation. The decline in proliferation was associated with increased activation
of protein kinase B (PKB) and the extracellular regulated kinase (ERK), suggesting a link
berween phosphatidyl inositol 5'-phosphatase activity of SHIP and Epo-mediated signal
transdr"rction pathways. Furthennore, these results were in line with data obtained from SHIP-
deficient rnice, which displayed reduced numbers of CFU-Es in ir uil i 'o colony assays ( I ).
One of the proteins that is highly activated in erythroid cells and has been linked to
erythroid dcvelopment and cell sr-rrvival is the signal transducer and activator of transcription
5 (STAT5). In chapter three, we show that both Epo and prostaglandin-E: (PGE:) contribute
to STAT5-signaling, but with different mechanisms. Wliile Epo itself strongly increases
STAT5 transactivation, PGE: only contributes to increased STAT5-signaling when
administered in combination with Epo. This PGE:-costimulation did not affect the init ial steps
in the STAT5-signaling cascade, including tyrosine phosphorylation, uclear translocation
and DNA-binding. Instead, we identifred a novel regulatory mechanistn that modulates
STAT5-signaling at the level of gene transactivation. This mechanism requires protein kinase
A (PKA)-mediatetl phosphorylation of the cAMP-response lement-binding protein (CREB)
and is sensitive to EIA-rnediated inhibit ion of the CREB-binding proteins CBP and p300'
These findings suggest hat phosphorylated CREB enhances the recruitment of CBP/p300 to
the transactivation complex, which results in enhanced transcriptional activity of STAT5. In
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addition, we observed Epo-dependent phosphorylation of STAT5A/B serine residues
1261731, but serinc phosphorylation did not increasc the transactivational potential of STAT5.
In chapter four we show that the synergy between SCF and Epo on erythropoiesis is
also reflected in a synergistic effect on STAT5-signaling. While SCF itself cannot induce
erythroid STAT5 activation, SCF strongly enhances STAT5 transactivation when
adrninistcred in addition with Epo. We observed that the synergistic effect of SCF on Epo-
rncdratcd S íA í5 transactrvatron was clepeníent on I'l(A activatron as il wÁ,s tíííu|ííít'tríí
synthctic PKA inhibitor H89 and by overexpression of PKA-inhibitor constructs.
Furthermore, the synergistic SCF effect was inhibited by overexprcssion of serine-mutated
CREB, demonstrating that PKA-mediatcd CREB phosphorylation is involved in the synergy
between Epo and SCF.
Since there are many sirnilarit ies between Epo-signaling in erythroid cells and
thrornbopoietin (TPO)-signaling in megakaryocytic ells, we examined the TPO-mediated
STAT5 transactivation i chapter f ive. Stimulation of megakaryocytic MOTe cells with TPO
rcsulted in strong STAT5 transactivation, which could be further enhanced by costimulation
with SCF. Thc underlying mechanism of this synergy, however, is different from erythroid
cells. In mcgakaryocytic MOTe cclls SCF enhanccs STAT5-signaling by upregulating TPO-
mediated tyrosine phosphorylation of STAT5 and STAT5 DNA-binding. Inhibition of PKA
did not affect the synergistic STAT5 transactivation, demonstrating that PI(A is not involved
in rncgakaryocytic STAT5-signaling.
In chapter six an overview is given of the cument knowledge regarding the role of
cAMP and PKA in the regulation of erythropoiesis. Special attention is given to the
intcraction between cAMP/PKA-signaling and additional signal transduction pathways. In
addition, the cAMP-rncdiated regulation of erythroid gene expression is discussed.
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